HMGA1 negatively regulates NUMB expression at transcriptional and post transcriptional level in glioblastoma stem cells

References

• Knoblich JA. Asymmetric cell division: recent developments and their implications for tumour biology. Nat Rev Mol Cell Biol. 2010;11:849–860. Review.
   PubMed Web of Science ®Google Scholar
• Lewis KM, Petritsch C. Asymmetric cell division: implications for glioma development and treatment. Transl Neurosci. 2013;4:484–503.
   PubMed Web of Science ®Google Scholar
• Sugiarto S, Persson AI, Munoz EG, et al. Asymmetry-defective oligodendrocyte progenitors are glioma precursors. Cancer Cell. 2011;20:328–340.
   PubMed Web of Science ®Google Scholar
• Bleeker FE, Molenaar RJ, Leenstra S. Recent advances in the molecular understanding of glioblastoma. J Neurooncol. 2012;108:11–27.
   PubMed Web of Science ®Google Scholar
• Fedele M, Fusco A. HMGA and cancer. Biochim Biophys Acta. 2010;1799:48–54. Review.
   PubMed Web of Science ®Google Scholar
• Colamaio M, Tosti N, Puca F, et al. HMGA1 silencing reduces stemness and temozolomide resistance in glioblastoma stem cells. Expert Opin Ther Targets. 2016;20:1169–1179.
   PubMed Web of Science ®Google Scholar
• Berlingieri MT, Manfioletti G, Santoro M, et al. Inhibition of HMGI-C protein synthesis suppresses retrovirally induced neoplastic transformation of rat thyroid cells. Mol Cell Biol. 1995;15:1545–1553.
   PubMed Web of Science ®Google Scholar
• Scala S, Portella G, Fedele M, et al. Adenovirus-mediated suppression of HMGI(Y) protein synthesis as potential therapy of human malignant neoplasias. Proc Natl Acad Sci U S A. 2000;97:4256–4261.
   PubMed Web of Science ®Google Scholar
• Berlingieri MT, Pierantoni GM, Giancotti V, et al. Thyroid cell transformation requires the expression of the HMGA1 proteins. Oncogene. 2002;21:2971–2980.
   PubMed Web of Science ®Google Scholar
• Vallone D, Battista S, Pierantoni GM, et al. Neoplastic transformation of rat thyroid cells requires the junB and fra-1 gene induction which is dependent on the HMGI-C gene product. Embo J. 1997;16:5310–5321.
   PubMed Web of Science ®Google Scholar
• Federico A, Forzati F, Esposito F, et al. Hmga1/Hmga2 double knock-out mice display a “superpygmy” phenotype. Biol Open. 2014;3:372–378.
   PubMed Web of Science ®Google Scholar
• Puca F, Colamaio M, Federico A, et al. HMGA1 silencing restores normal stem cell characteristics in colon cancer stem cells by increasing p53 levels. Oncotarget. 2014;5:3234–3245.
   PubMed Web of Science ®Google Scholar
• Pierantoni GM, Conte A, Rinaldo C, et al. Deregulation of HMGA1 expression induces chromosome instability through regulation of spindle assembly checkpoint genes. Oncotarget. 2015;6:17342–17353.
   PubMedGoogle Scholar
• Pegoraro S, Ros G, Piazza S, et al. HMGA1 promotes metastatic processes in basal-like breast cancer regulating EMT and stemness. Oncotarget. 2013;4:1293–1308.
   PubMed Web of Science ®Google Scholar
• D’Angelo D, Mussnich P, Rosa R, et al. High mobility group A1 protein expression reduces the sensitivity of colon and thyroid cancer cells to antineoplastic drugs. BMC Cancer. 2014;14:851.
   PubMed Web of Science ®Google Scholar
• Pece S, Confalonieri S, Romano PR, et al. NUMB-ing down cancer by more than just a NOTCH. Biochim Biophys Acta. 2011;1815:26–43.
   PubMed Web of Science ®Google Scholar
• Shen Q, Zhong W, Jan YN, et al. Asymmetric Numb distribution is critical for asymmetric cell division of mouse cerebral cortical stem cells and neuroblasts. Development. 2002;129:4843–4853.
   PubMed Web of Science ®Google Scholar
• Caussinus E, Gonzalez C. Induction of tumor growth by altered stem-cell asymmetric division in Drosophila melanogaster. Nat Genet. 2005;37:1125–1129.
   PubMed Web of Science ®Google Scholar
• Colaluca IN, Tosoni D, Nuciforo P, et al. NUMB controls p53 tumour suppressor activity. Nature. 2008;451:76–80.
   PubMed Web of Science ®Google Scholar
• Kang Y, Ding M, Tian G, et al. Overexpression of Numb suppresses tumor cell growth and enhances sensitivity to cisplatin in epithelioid malignant pleural mesothelioma. Oncol Rep. 2013;30:313–319.
   PubMed Web of Science ®Google Scholar
• Jiang X, Xing H, Kim TM, et al. Numb regulates glioma stem cell fate and growth by altering epidermal growth factor receptor and Skp1-Cullin-F-box ubiquitin ligase activity. Stem Cells. 2012;30:1313–1326.
   PubMed Web of Science ®Google Scholar
• Sato K, Watanabe T, Wang S, et al. NUMB controls E-cadherin endocytosis through p120 catenin with aPKC. Mol Biol Cell. 2011;22:3103–3119.
   PubMed Web of Science ®Google Scholar
• Wang Z, Sandiford S, Wu C, et al. Numb regulates cell-cell adhesion and polarity in response to tyrosine kinase signalling. Embo J. 2009;28:2360–2373.
   PubMed Web of Science ®Google Scholar
• Liu XH, Wu Y, Yao S, et al. Androgens up-regulate transcription of the Notch inhibitor Numb in C2C12 myoblasts via Wnt/β-catenin signaling to T cell factor elements in the Numb promoter. J Biol Chem. 2013;288:17990–17998.
   PubMed Web of Science ®Google Scholar
• Kawahara H, Imai T, Imataka H, et al. Neural RNA-binding protein Musashi1 inhibits translation initiation by competing with eIF4G for PABP. J Cell Biol. 2008;181:639–653.
   PubMed Web of Science ®Google Scholar
• Hwang WL, Jiang JK, Yang SH, et al. MicroRNA-146a directs the symmetric division of Snail-dominant colorectal cancer stem cells. Nat Cell Biol. 2014;16:268–280.
   PubMed Web of Science ®Google Scholar
• Pece S, Serresi M, Santolini E, et al. Loss of negative regulation by Numb over Notch is relevant to human breast carcinogenesis. J Cell Biol. 2004;167:215–221.
   PubMed Web of Science ®Google Scholar
• Wang J, Wang C, Meng Q, et al. siRNA targeting Notch-1 decreases glioma stem cell proliferation and tumor growth. Mol Biol Rep. 2012;39:2497–2503.
   PubMed Web of Science ®Google Scholar
• Battista S, Pentimalli F, Baldassarre G, et al. Loss of Hmga1 gene function affects embryonic stem cell lympho-hematopoietic differentiation. Faseb J. 2003;17:1496–1498.
   PubMed Web of Science ®Google Scholar
• Battista S, Fedele M, Martinez Hoyos J, et al. High-mobility-group A1 (HMGA1) proteins down-regulate the expression of the recombination activating gene 2 (RAG2). Biochem J. 2005;389(Pt 1):91–97.
   PubMedGoogle Scholar
• Messeguer X, Escudero R, Farré D, et al. PROMO: detection of known transcription regulatory elements using species-tailored searches. Bioinformatics. 2002;18:333–334.
   PubMed Web of Science ®Google Scholar
• LaMarca HL, Visbal AP, Creighton CJ, et al. CCAAT/enhancer binding protein beta regulates stem cell activity and specifies luminal cell fate in the mammary gland. Stem Cells. 2010;28:535–544.
   PubMed Web of Science ®Google Scholar
• Nerlov C. The C/EBP family of transcription factors: a paradigm for interaction between gene expression and proliferation control. Trends Cell Biol. 2007;17:318–324. Review.
   PubMed Web of Science ®Google Scholar
• Foti D, Iuliano R, Chiefari E, et al. A nucleoprotein complex containing Sp1, C/EBP beta, and HMGI-Y controls human insulin receptor gene transcription. Mol Cell Biol. 2003;23:2720–2732.
   PubMed Web of Science ®Google Scholar
• McGill MA, McGlade CJ. Mammalian numb proteins promote Notch1 receptor ubiquitination and degradation of the Notch1 intracellular domain. J Biol Chem. 2003;278:23196–23203.
   PubMed Web of Science ®Google Scholar
• McGill MA, Dho SE, Weinmaster G, et al. Numb regulates post-endocytic trafficking and degradation of Notch1. J Biol Chem. 2009;284:26427–26438.
   PubMed Web of Science ®Google Scholar
• Aguilar-Morante D, Cortes-Canteli M, Sanz-Sancristobal M, et al. Decreased CCAAT/enhancer binding protein β expression inhibits the growth of glioblastoma cells. Neuroscience. 2011;176:110–119.
   PubMed Web of Science ®Google Scholar
• Zahnow CA. CCAAT/enhancer-binding protein beta: its role in breast cancer and associations with receptor tyrosine kinases. Expert Rev Mol Med. 2009;11:e12.
   PubMed Web of Science ®Google Scholar
• Glazer RI, Vo DT, Penalva LO. Musashi1: an RBP with versatile functions in normal and cancer stem cells. Front Biosci (Landmark Ed). 2012;17:54–64.
   PubMed Web of Science ®Google Scholar
• Kudinov AE, Karanicolas J, Golemis EA, et al. Musashi RNA-binding proteins as cancer drivers and novel therapeutic targets. Clin Cancer Res. 2017;23:2143–2153.
   PubMed Web of Science ®Google Scholar
• Shah SN, Cope L, Poh W, et al. HMGA1: a master regulator of tumor progression in triple-negative breast cancer cells. PLoS One. 2013;8:e63419.
   PubMed Web of Science ®Google Scholar
• Liu XS, Fan BY, Pan WL, et al. Identification of miRNomes associated with adult neurogenesis after stroke using Argonaute 2-based RNA sequencing. RNA Biol. 2017;14:488–499.
   PubMed Web of Science ®Google Scholar
• Hu YY, Zheng MH, Cheng G, et al. Notch signaling contributes to the maintenance of both normal neural stem cells and patient-derived glioma stem cells. BMC Cancer. 2011;11:82.
   PubMed Web of Science ®Google Scholar
• Ito T, Kwon HY, Zimdahl B, et al. Regulation of myeloid leukaemia by the cell-fate determinant Musashi. Nature. 2010;466:765–768.
   PubMed Web of Science ®Google Scholar
• Westhoff B, Colaluca IN, D’Ario G, et al. Alterations of the Notch pathway in lung cancer. Proc Natl Acad Sci U S A. 2009;106:22293–22298.
   PubMed Web of Science ®Google Scholar
• Bu P, Wang L, Chen KY, et al. A miR-34a-numb feedforward loop triggered by inflammation regulates asymmetric stem cell division in intestine and colon cancer. Cell Stem Cell. 2016;18:189–202.
   PubMed Web of Science ®Google Scholar
• Donato G, Martinez Hoyos J, Amorosi A, et al. High mobility group A1 expression correlates with the histological grade of human glial tumors. Oncol Rep. 2004;11:1209–1213.
   PubMed Web of Science ®Google Scholar